Evaluating Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and Treatment
Keywords:
DOACs, anticoagulant, antiplatelet, thromboembolic diseases, stroke prevention, venous thromboembolism, atrial fibrillationAbstract
Infarction of the deep veins (DVT) and pulmonary embolism, and stroke are examples of thromboembolic illnesses that are principal causes of mortality and morbidity on a global scale. The development of novel anticoagulant and antiplatelet medications has fundamentally changed the prevention and treatment of these illnesses. This article evaluates the safety and efficacy of these cutting-edge therapeutic treatments, with a focus on direct oral anticoagulants (DOACs) and new antiplatelet drugs. An examination of recent clinical trials and real-world data provides a comprehensive assessment of their benefits and drawbacks.
References
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., et al. (2009). Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 361(12), 1139-1151.
Patel, M. R., Mahaffey, K. W., Garg, J., et al. (2011). Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine, 365(10), 883-891.
Granger, C. B., Alexander, J. H., McMurray, J. J., et al. (2011). Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365(11), 981-992.
Giugliano, R. P., Ruff, C. T., Braunwald, E., et al. (2013). Edoxaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 369(22), 2093-2104.
Wallentin, L., Becker, R. C., Budaj, A., et al. (2009). Ticagrelor versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 361(11), 1045-1057.
Wiviott, S. D., Braunwald, E., McCabe, C. H., et al. (2007). Prasugrel versus clopidogrel in patients with acute coronary syndromes. New England Journal of Medicine, 357(20), 2001-2015.
Ruff, C. T., Giugliano, R. P., Braunwald, E., et al. (2014). Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. The Lancet, 383(9921), 955-962.
Serebruany, V. L., Tomek, A., & Kim, M. H. (2016). Real-world comparisons of ticagrelor and prasugrel efficacy and safety after percutaneous coronary interventions. Cardiology, 134(2), 167-176.
Jiyanboyevich, Y. S., Aslam, I., Ravshanovna, M. U., Azamatovna, F. G., & Murodovna, J. D. (2021). Ventricular Arrhythmias With Congenital Heart Disease Causing Sudden Death. NVEO-NATURAL VOLATILES & ESSENTIAL OILS Journal| NVEO, 2055-2063.
Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.
Arslonova, R. R., & Nagmatullayev, U. A. (2023). Evaluation of the Clinical Efficacy of Phenytoin in the Treatment of Epileptic Seizures in Children. World Journal of Agriculture and Urbanization, 2(6), 14-17.
Aslam, I., Rasheed, N., Mumtaz, Z., Abbas, M., Waseem, S., & Mohsen, A. A. (2023). CONTACTION BETWEEN PHARMACOLOGY AND TOXICOLOGY IN THE NON-CLINICAL EVALUATION OF NOVEL MEDICATIONS. NeuroQuantology, 21(6), 352.
Aslam, I., Jiyanboyevich, Y. S., Ergashboevna, A. Z., Farmanovna, I. E., & Rajabboevna, A. R. (2021). Novel oral anticoagulants for treatment of deep venous thrombosis and pulmonary embolism. Eurasian Research Bulletin, 1(1), 59-72.
Shaikh, S. A., & Aslam, I. (2024). SEMAGLUTIDE REDUCED CARDIOVASCULAR EVENTS BY 20% IN CERTAIN ADULTS. Science and innovation, 3(Special Issue 28), 272.
Aslam, I., Asadullah, R. N. A., Akhlaq, F., Ali, A., & Fatima, A. (2023). Diabetic Disease and its 2-4 Fold Mortality Rate, Patients Getting Standard Therapy in the Modern ERA of CVD Risk Reduction. Pakistan Journal of Medical & Health Sciences, 17(01), 420-420.
Aslam, I., Ashraf, A., Ergashboevna, A. Z., & Ergashboevna, E. M. (2024). Demographic and Clinical Profile Of Chronic Myeloid Leukemia Patients in a Resource-Limited Setting: A Comprehensive Analysis. International Journal of Integrative and Modern Medicine, 2(5), 128-133.
Aslam, I., Zafar, H., Majeed, F., Younus, A., Ashiq, H., & Arif, F. (2023). HEART FAILURE PREDICTION THROUGH PROTEOMICPROFILING AMONG ELDERLY PATIENTS. NeuroQuantology, 21(6), 765.
Eshkobilova M. E., Хodieva N., Abdurakhmanova Z. E. Thermocatalytic and Semiconductor Sensors for Monitoring Gas Mixtures //World Journal of Agriculture and Urbanization. – 2023. – Т. 2. – №. 6. – С. 9-13.
bibitem[Abdurakhmonov et al.(2024)]{2024E3SWC.48605015A} Abdurakhmonov, E., Murodova, Z.~B., Abdurakhmanova, Z., et al. 2024, E3S Web of Conferences, 486, 05015. doi:10.1051/e3sconf/202448605015
Ergashboevna, E. M. ., & E., A. Z. . (2023). Creation of Selective Sensors and Alarms for Monitoring Carbon Dioxide and Methane. World Journal of Agriculture and Urbanization, 2(6), 22–26. https://doi.org/10.51699/wjau.v2i6.72
ЁПИҚ ЭКОЛОГИК ТИЗИМЛАР ҲАВОСИДА ИС ГАЗИ ВА МЕТАННИ ТЎПЛАНИШИНИ НАЗОРАТИ УЧУН СИГНАЛИЗАТОР Ёрбекова Севинч Ёқубжон қизи СамДТУ 3 курс талабаси Абдугаффаров Жавохир Шухрат ўғли СамДТУ 1-курс талабаси Абдурахмонова Замира Эргашбоевна СамДТУ ассисент Эшқобилова Мавжуда Эргашбоевна СамДТУ доцент. (2024). ЁПИҚ ЭКОЛОГИК ТИЗИМЛАР ҲАВОСИДА ИС ГАЗИ ВА МЕТАННИ ТЎПЛАНИШИНИ НАЗОРАТИ УЧУН СИГНАЛИЗАТОР. Research focus international scientific journal, 3(2). https://doi.org/10.5281/zenodo.10714493
Abdurakhmanov, Ilhom & Abdurakhmanov, E. & Abdurakhmanova, Z. & Erdanov, Y.T.. (2022). DEVELOPMENT OF SELECTIVE SEMICONDUCTOR SENSORS OF HYDROGEN SULFIDE, AMMONIA, AND METHANE USING NANOMATERIALS OBTAINED BY THE SOL-GEL PROCESS. RASAYAN Journal of Chemistry. 15. 2676-2679. 10.31788/RJC.2022.1548017.
Hikmatovich I. N. et al. Local Treatment of Children with Atopic Dermatitis //International Journal of Innovative Analyses and Emerging Technology. – 2021. – Т. 1. – №. 5. – С. 235-237.
Aslam I., Jiyanboyevich Y. S., Ergashboevna A. Z. Prevention & Treatment Of Cardiovascular Diseases //The American Journal of Medical Sciences and Pharmaceutical Research. – 2021. – Т. 3. – №. 06. – С. 180-188.
Aslam I. et al. Novel oral anticoagulants for treatment of deep venous thrombosis and pulmonary embolism //Eurasian Research Bulletin. – 2021. – Т. 1. – №. 1. – С. 59-72.
Мамиров В. А. и др. Эффективность комбинированной терапии при очаговой алопеции //Вопросы науки и образования. – 2019. – №. 31 (81). – С. 52-57.
Aslam I. et al. Muscle Relaxant for Pain Management //Open Access Repository. – 2022. – Т. 8. – №. 1. – С. 1-4.
Murodovna J. D. et al. ABU-THE ROLE OF THE TEACHINGS OF ALI IBN SINA IN THE UPBRINGING OF A HARMONIOUSLY DEVELOPED GENERATION //Web of Scientist: International Scientific Research Journal. – 2022. – Т. 3. – №. 5. – С. 1522-1526.
Abdurakhmanov E. et al. Development of a selective carbon monoxide sensor //IOP Conference Series: Earth and Environmental Science. – IOP Publishing, 2021. – Т. 839. – №. 4. – С. 042078.
Джумаева Н. С., Восеева Д. Х., Абдурахмонова З. Э. Современный взгляд на лечение лямблиоза //Достижения науки и образования. – 2020. – №. 16 (70). – С. 65-69.
Eshkabilova M. et al. Development of selective gas sensors using nanomaterials obtained by sol-gel process //Journal of Physics: Conference Series. – IOP Publishing, 2022. – Т. 2388. – №. 1. – С. 012155.
Murodova Z., Hushvaktov M., Abdurahmanova Z. Some issues of the mechanism of deep oxidation of ethanol on the surface of the catalyst of a thermocatalytic sensor //EurasianUnionScientists. – 2021. – С. 27-32.
Rajabboevna A. R., Farmanovna I. E., Ergashboevna A. Z. YOD TANQISLIGI FONIDA BOLALARDA SHAKLLANISH VA RIVOJLANISH BUZILISHLARNING O’ZIGA XOS XUSUSIYATLARI //BAR
Aslam I. et al. Demographic and Clinical Profile Of Chronic Myeloid Leukemia Patients in a Resource-Limited Setting: A Comprehensive Analysis //International Journal of Integrative and Modern Medicine. – 2024. – Т. 2. – №. 5. – С. 128-133.QARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – С. 350-352.
Farmanovna I. E., Ergashboevna A. Z. ANGIOTENZIN KONVERSIYALOVCHI FERMENT INGIBITORLARINING KLINIK AMALIYOTDA QO’LLANILISHI //BARQARORLIK VA YETAKCHI TADQIQOTLAR ONLAYN ILMIY JURNALI. – 2022. – С. 513-517.
bibitem[Abdurakhmonov et al.(2024)]{2024E3SWC.48605015A} Abdurakhmonov, E., Murodova, Z.~B., Abdurakhmanova, Z., et al. 2024, E3S Web of Conferences, 486, 05015. doi:10.1051/e3sconf/202448605015
DR I. A. et al. NEW DAY IN MEDICINE //NEW DAY IN MEDICINE Учредители: Бухарский государственный медицинский институт, ООО" Новый день в медицине". – №. 5. – С. 13-18.
Махмудова А. Н. и др. Медицина Узбекистана-достижения и перспективы развития сферы //Достижения науки и образования. – 2020. – №. 3 (57). – С. 49-52.
